SPG11 and Cognitive impairment: Loss of function may affect axonal transport and autolysosomes accumulation, contributing to diffuse neurodegeneration and causing clinical heterogeneity (presenting ataxia, parkinsonism or cognitive impairment in addition to core feature of spastic gait) in SPG11-related HSP-TCC [28, 29].